← FDA Drug Approvals (Drugs@FDA)

GLYCOPYRROLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-10-26

Drug application

FDA Application #

ANDA214635

Application type

Abbreviated New Drug Application (Generic)

Brand name

GLYCOPYRROLATE

Generic name

GLYCOPYRROLATE

Active ingredients

GLYCOPYRROLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2022-10-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown